| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 17 |
| 1 | ACETAMINOPHEN | 1 |
| 2 | ACETAMINOPHEN 500MG | 1 |
| 3 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 4 | AVATROMBOPAG MALEATE | 1 |
| 5 | CARBOPLATIN | 1 |
| 6 | DOCUSATE SODIUM | 1 |
| 7 | DOCUSATE SODIUM - SENNOSIDES | 1 |
| 8 | FENTANYL | 1 |
| 9 | LENVATINIB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AVATROMBOPAG MALEATE | 1 | 0.0004 |
| 1 | BEVACIZUMAB | 17 | 0.0001 |
| 2 | LENVATINIB | 1 | 0.0000 |
| 3 | TAPENTADOL HYDROCHLORIDE | 1 | 0.0000 |
| 4 | DOCUSATE SODIUM | 1 | 0.0000 |
| 5 | FENTANYL | 1 | 0.0000 |
| 6 | PACLITAXEL | 1 | 0.0000 |
| 7 | CARBOPLATIN | 1 | 0.0000 |
| 8 | PREGABALIN | 1 | 0.0000 |
| 9 | ACETAMINOPHEN | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 17 |
| 1 | Microtubule Inhibitor [EPC] | 1 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 |
| 3 | Opioid Agonist [EPC] | 1 |
| 4 | Platinum-based Drug [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 17 | 0.0001 |
| 1 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Opioid Agonist [EPC] | 1 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |